Literature DB >> 18309003

Pottransplantation anemia: management and rationale.

Wolfgang C Winkelmayer1, Anil Chandraker.   

Abstract

In recent years, there has been an increasing interest in studying the anemia that occurs after kidney transplantation. Although many of the guidelines for the treatment of kidney transplant patients, including those for anemia, are extrapolated from recommendations for patients with chronic kidney disease, there are important differences in the cause of and response to anemia in kidney transplant recipients. In addition to the correlation of anemia with kidney function as in native renal disease, many other factors are associated with the development of anemia after transplantation, including the use of medications and the inflammation/immune response. Given the lack of large, well-designed, prospective studies, the consequences of anemia, the response to treatment, and the cost-effectiveness of treatment in the posttransplantation setting are also poorly understood.

Entities:  

Mesh:

Year:  2008        PMID: 18309003      PMCID: PMC3152277          DOI: 10.2215/CJN.03290807

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  41 in total

1.  Anemia following renal transplantation.

Authors:  H C Kim; S B Park; S Y Han; E A Whang
Journal:  Transplant Proc       Date:  2003-02       Impact factor: 1.066

Review 2.  Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy.

Authors:  Lutz Liefeldt; Martin Buhl; Britta Schweickert; Elisabeth Engelmann; Orhan Sezer; Peter Laschinski; Lothar Preuschof; Hans-H Neumayer
Journal:  Nephrol Dial Transplant       Date:  2002-10       Impact factor: 5.992

3.  Parvovirus B19 in kidney transplant patients.

Authors:  Z R Zolnourian; M D Curran; B K Rima; P V Coyle; H J O'Neill; D Middleton
Journal:  Transplantation       Date:  2000-05-27       Impact factor: 4.939

4.  Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease.

Authors:  Claudio Rigatto; Patrick Parfrey; Robert Foley; Carol Negrijn; Carrie Tribula; John Jeffery
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

Review 5.  Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

6.  Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation.

Authors:  Kim T Sinnamon; Aisling E Courtney; A Peter Maxwell; Peter T McNamee; Geraldine Savage; Damian G Fogarty
Journal:  Nephrol Dial Transplant       Date:  2007-03-12       Impact factor: 5.992

7.  Anemia and iron deficiencies among long-term renal transplant recipients.

Authors:  Matthias Lorenz; Josef Kletzmayr; Agnes Perschl; Alexander Furrer; Walter H Hörl; Gere Sunder-Plassmann
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

8.  Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?

Authors:  Peter D Yorgin; John D Scandling; Amir Belson; Jaime Sanchez; Steven R Alexander; Kenneth A Andreoni
Journal:  Am J Transplant       Date:  2002-05       Impact factor: 8.086

9.  Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays.

Authors:  Mei-Sze Chua; Christopher Barry; Xin Chen; Oscar Salvatierra; Minnie M Sarwal
Journal:  Am J Transplant       Date:  2003-01       Impact factor: 8.086

10.  Prevalence and management of anemia in renal transplant recipients: a European survey.

Authors:  Yves Vanrenterghem; Claudio Ponticelli; José Maria Morales; Daniel Abramowicz; Keshwar Baboolal; Björn Eklund; Volker Kliem; Christophe Legendre; Antonio Luis Morais Sarmento; Flavio Vincenti
Journal:  Am J Transplant       Date:  2003-07       Impact factor: 8.086

View more
  15 in total

1.  Deceased donor kidney transplant complicated by spontaneous rupture of native kidney in a HIV patient.

Authors:  Stephanie Lombardi; Heather L Kutzler; Sara Moradi; Bejon Maneckshana; Patricia Sheiner; Caroline Rochon; Oscar K Serrano
Journal:  CEN Case Rep       Date:  2020-01-27

2.  Diagnostic application of the A(1c) assay in renal disease.

Authors:  Adnan Sharif; Keshwar Baboolal
Journal:  J Am Soc Nephrol       Date:  2010-02-04       Impact factor: 10.121

Review 3.  Primary care of the renal transplant patient.

Authors:  Gaurav Gupta; Mark L Unruh; Thomas D Nolin; Peggy B Hasley
Journal:  J Gen Intern Med       Date:  2010-04-27       Impact factor: 5.128

4.  Does posttransplant anemia at 6 months affect long-term outcome of live-donor kidney transplantation? A single-center experience.

Authors:  Osama Gheith; Ehab Wafa; Nabil Hassan; Amani Mostafa; Hussein A Sheashaa; Khaled Mahmoud; Ahmed Shokeir; Mohamed A Ghoneim
Journal:  Clin Exp Nephrol       Date:  2009-04-07       Impact factor: 2.801

5.  Post-renal transplantation anemia at 12 months: prevalence, risk factors, and impact on clinical outcomes.

Authors:  Zhongli Huang; Turun Song; Lei Fu; Zhengsheng Rao; Dongyang Zeng; Yang Qiu; Xianding Wang; Libo Xie; Qiang Wei; Li Wang; Tao Lin
Journal:  Int Urol Nephrol       Date:  2015-08-06       Impact factor: 2.370

6.  Renal association clinical practice guideline in post-operative care in the kidney transplant recipient.

Authors:  Richard J Baker; Patrick B Mark; Rajan K Patel; Kate K Stevens; Nicholas Palmer
Journal:  BMC Nephrol       Date:  2017-06-02       Impact factor: 2.388

7.  The association of early post-transplant glucose levels with long-term mortality.

Authors:  T G Valderhaug; J Hjelmesæth; A Hartmann; J Røislien; H A Bergrem; T Leivestad; P D Line; T Jenssen
Journal:  Diabetologia       Date:  2011-03-16       Impact factor: 10.122

8.  New-onset diabetes after renal transplantation: risk assessment and management.

Authors:  Lidia Ghisdal; Steven Van Laecke; Marc J Abramowicz; Raymond Vanholder; Daniel Abramowicz
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

Review 9.  Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors.

Authors:  Gianluigi Zaza; Paola Tomei; Paolo Ria; Simona Granata; Luigino Boschiero; Antonio Lupo
Journal:  Clin Dev Immunol       Date:  2013-09-19

10.  Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study.

Authors:  Georg Heinze; Alexander Kainz; Walter H Hörl; Rainer Oberbauer
Journal:  BMJ       Date:  2009-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.